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The Brucella abortus type IV secretion system (T4SS), encoded by the virB genes, is essential for survival in
mononuclear phagocytes in vitro. In the mouse model, a B. abortus virB mutant was initially able to colonize
the spleen at the level of the wild type for approximately 3 to 5 days, which coincided with the development of
adaptive immunity. To investigate the relationship between survival in macrophages cultivated in vitro and
persistence in tissues in vivo, we tested the ability of mutant mice lacking components of adaptive immunity
to eliminate the virB mutant from the spleen during a mixed infection with the B. abortus wild type. Ifng/ or
2m
/ mice were able to clear the virB mutant to the same degree as control mice. However, spleens of
Rag1/ mice and Igh6/ mice were more highly colonized by the virB mutant than control mice after 14 to
21 days, suggesting that, in these mice, there is not an absolute requirement for the T4SS to mediate
persistence of B. abortus in the spleen. Macrophages isolated from Igh6/ mice killed the virB mutant to the
same extent as macrophages from control mice, showing that the reduced ability of these mice to clear the virB
mutant from the spleen does not correlate with diminished macrophage function in vitro. These results show
that in the murine model host, the T4SS is required for persistence beyond 3 to 5 days after infection and
suggest that the T4SS may contribute to evasion of adaptive immune mechanisms by B. abortus.
Brucella abortus is one of the causative agents of brucellosis,
a chronic zoonotic infection characterized by bacterial persis-
tence in the reticuloendothelial system (RES) of the liver,
spleen, and lymph nodes. The chronic infection of the RES
observed during human brucellosis can be studied in the mu-
rine model host. A signature-tagged transposon screen identi-
fied a type IV secretion system (T4SS) as an essential virulence
factor for persistence in the murine RES (11). The T4SS is
encoded by the virB locus on chromosome II of the B. abortus
genome. Mutational inactivation of the T4SS reduces the abil-
ity of B. abortus to survive and/or replicate in human epithelial
cell lines (HeLa cells), murine bone marrow-derived macro-
phages, and macrophage-like cell lines (3, 5, 8, 14, 29, 30), and
similar phenotypes have been described for Brucella melitensis
and Brucella suis virB mutants (7, 10, 16, 24). Within murine
bone marrow-derived macrophages, B. abortus traffics to an
endoplasmic reticulum (ER)-like compartment, where it local-
izes to ER exit sites. In contrast, virB mutants fail to acquire
ER markers (3, 4). These differences in cellular trafficking are
reflected in the kinetics of bacterial growth and/or killing:
whereas wild-type (wt) B. abortus is able to replicate in mac-
rophages in vitro, virB mutant bacteria are eliminated within
the first 24 h after infection (3, 29, 30).
These observations raise the question whether the T4SS is
required for evasion of macrophage killing mechanisms in vivo.
The role of the T4SS in evading two major macrophage killing
mechanisms was recently addressed by comparing the ability of
mice defective for production of reactive nitrogen interme-
diates (Nos2/ mice) and reactive oxygen intermediates
(gp91phox/mice) with their congenic wild-type mice to
check growth of B. abortus and an isogenic virB mutant in the
RES. This study showed that neither the inducible nitric oxide
synthase nor NADPH oxidase was responsible for the severe in
vivo growth defect of the virB mutant (30).
Since B. abortus virB mutants are 100-fold attenuated for
intracellular growth within only 5 to 8 h of in vitro infection of
macrophages, it seems reasonable to expect that, if bacteria
entered macrophages at the onset of infection, then attenua-
tion in vivo should manifest early during infection of mice as
well. However, a recent screen of 672 Brucella melitensis sig-
nature-tagged transposon mutants for genes required for col-
onization of murine spleens 5 days after infection did not
identify any transposon insertions in the virB locus (18). This
result was somewhat puzzling, since screening of a smaller B.
abortus signature-tagged mutant bank (178 mutants) in mice
identified two insertions in the virB locus (11). One major
difference in the design of the latter screen was the recovery of
mutants from the spleen at 2 weeks and 8 weeks after infection.
A possible interpretation of these in vivo data is that, unlike
during in vitro growth in host cells, the T4SS is only required
for bacterial growth in the RES at late times (5 days) after
infection. In order to address this question experimentally, we
studied the kinetics of infection of a virB mutant in both wild-
type and mutant mouse strains.
MATERIALS AND METHODS
Bacterial strains, media, and culture conditions. Bacterial strains used were
Brucella abortus 2308 and its isogenic mutant, BA41 (11), which has an insertion
of mTn5Km2 at nucleotide 1232 of the B. abortus virB locus (GenBank accession
number AF226278). This insertion is located 59 bp downstream of the virB1 gene
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and is polar on the expression of downstream genes in the virB operon (31).
Strains were cultured on tryptic soy agar (TSA; Difco/Becton-Dickinson, Sparks,
MD) or in tryptic soy broth at 37°C on a rotary shaker. Bacterial inocula for
infection of mice were cultured on TSA plus 5% blood (1). For cultures of strain
BA41, kanamycin (Km) was added to the culture medium at 100 mg/liter. All
work with live B. abortus was performed at biosafety level 3.
Infection of mice. C57BL/6, B6.129S7-Rag1tm1Mom (21) mice carrying a tar-
geted knockout of the gene encoding recombination activating gene 1, B6.129S2-
Cd4tm1Cgn (27) mice carrying a targeted knockout of the gene encoding CD4,
B6.129S2, Igh-6tm1Mak (15) mice carrying a targeted knockout of the gene en-
coding immunoglobulin Mu chain, and B6.129S7-Ifngtm1Ts/J (6) mice carrying a
targeted knockout of the gene encoding interferon gamma (IFN-) were ob-
tained from the Jackson Laboratory (Bar Harbor, ME). B6 and B6.129-
B2mtm1JaeN12 (33) mice carrying a targeted knockout of the gene encoding
2-microglobulin were obtained from Taconic Farms (Germantown, NY). Mice
were held in microisolator cages with sterile bedding and water and irradiated
feed in a biosafety level 3 facility. For infection experiments, groups of five
knockout mice and five age-matched controls per time point were inoculated
intraperitoneally (i.p.) with 0.1 ml of phosphate-buffered saline (PBS) containing
5 105 to 10 105 CFU of B. abortus. At the appropriate time points, mice were
euthanized by CO2 asphyxiation, and the spleens were collected aseptically at
necropsy. The spleens were homogenized in 3 ml of PBS, and serial dilutions of
the homogenate were plated on TSA and TSA plus Km for enumeration of CFU.
For mixed infection experiments, the log ratio was calculated as the geometric
mean of CFU mutant/CFU wild type recovered from spleens. Experimental
groups each contained five knockout mice and five age-matched controls from
the same supplier, aged 6 to 10 weeks. All animal experiments were approved by
the Texas A&M University Laboratory Animal Care and Use Committee or the
UC Davis Institutional Animal Care and Use Committee and were conducted in
accordance with institutional guidelines.
Confirmation of mutant mouse phenotypes. Flow cytometry analysis was used
to confirm mutant phenotypes of 2m/, Cd4/, and Igh6/ mice. Spleens
from infected mice were homogenized in 3 ml PBS, and serial dilutions were
plated on TSA or TSA plus Km to enumerate CFU. The remaining cells were
labeled for analysis by flow cytometry. Briefly, after passing the cells through a
100-m cell strainer and treating the samples with ACK buffer (0.15 M NH4Cl,
1.0 mM KHCO3, 0.1 mM Na2EDTA, pH 7.2) to lyse red blood cells, the cells
were washed with PBS (Gibco) containing 1% bovine serum albumin (PBS-
BSA). Portions of the splenocytes were stained at 4°C with the appropriate
monoclonal antibodies (MAb): either fluorescein isothiocyanate (FITC)-conju-
gated rat anti-mouse CD8a (Ly-2) MAb, FITC-conjugated rat anti-mouse
CD45R/B220 MAb (Pharmingen, San Diego, CA), or FITC-conjugated rat anti-
mouse CD4 (L3T4) MAb. The cells were washed with PBS-BSA and fixed with
4% formaldehyde for 1 h. Finally, samples were washed as before and resus-
pended in PBS-BSA. Flow cytometry analysis was performed using a FACSCalibur
(Becton Dickinson, San Diego, CA), and data were collected for 10,000 cells/
sample (data not shown). Mice that did not exhibit the expected phenotypes were
eliminated from the data analysis.
Isolation of bone marrow-derived macrophages. Bone marrow-derived mac-
rophages were isolated from C57BL/6, Igh6/, and Cd4/ mice following
standard protocols. Briefly, after aseptically obtaining femurs from the mice, the
bone marrow cells were flushed out with 6 ml of cold RPMI medium 1690
(RPMI; Gibco, Rockville, MD). Cells were pelleted at 1,000 rpm for 10 min at
4°C. The cells were resuspended in BMM medium (RPMI supplemented with
20% heat-inactivated fetal bovine serum, L-cell conditioned medium, 1 mM
glutamine, 1% nonessential amino acids, and 1% antibiotic-antimycotic [Gibco,
Rockville, MD]) and placed in petri dishes at 37°C in 5% CO2. At day 3 cells
were fed by adding 10 ml of BMM medium and incubated for an additional 5
days in the presence of CO2. At day 7, the bone marrow-derived macrophages
were harvested by removing the medium and adding cold PBS. Macrophages
were centrifuged at 1,000 rpm for 10 min at 4°C, resuspended in RPMIsup
(RPMI supplemented with 20% heat-inactivated fetal bovine serum, 1 mM
glutamine, and 1% nonessential amino acids), and counted for the infection
assays.
Isolation of resident peritoneal macrophages. Resident peritoneal macro-
phages were isolated from C57BL/6, Igh6/, and Cd4/ post mortem, follow-
ing standard protocols. Briefly, peritoneal fluid was harvested after injecting the
animal’s abdomens with cold RPMI supplemented with heparin. After injection,
the abdomen of the animal was massaged and the liquid was extracted from the
peritoneal cavity. Fluids were centrifuged at 1,200 rpm for 10 min at 4°C, and the
pellets were resuspended in RPMI supplemented with 20% heat-inactivated fetal
bovine serum, 1 mM glutamine, 1% nonessential amino acids, and 1% antibiotic-
antimycotic (Gibco, Rockville, MD) and placed in petri dishes at 37°C in 5%
CO2. After incubation for 3 h at 37°C under 5% CO2, nonadherent cells were
removed from the petri dishes by aspiration, and the adherent macrophages were
rinsed twice with PBS, counted, and plated in 24-well plates with fresh medium
without antibiotic-antimycotic for subsequent infection.
Splenic adherent cells. Splenic cells were isolated from C57BL/6 and Igh6/
mice by homogenizing spleens in 3 ml of RPMI supplemented with 20% heat-
inactivated fetal bovine serum, 1 mM glutamine, 1% nonessential amino acids,
and 1% antibiotic-antimycotic (Gibco, Rockville, MD). Cells were centrifuged at
1,000 rpm for 10 min at 4°C. The cells were resuspended in 10 ml of the above
medium and placed in petri dishes at 37°C in 5% CO2 overnight. The nonad-
herent cells were removed from the petri dishes by aspiration, and the adherent
cells were rinsed twice with PBS, counted, and plated in 24-well plates with fresh
medium without antibiotic-antimycotic for subsequent infection.
Macrophage infection. For macrophage killing assays, 24-well microtiter plates
were seeded with macrophages at a concentration of 2 105 cells/well in 0.5 ml
of RPMIsup and incubated overnight at 37°C in 5% CO2. The inocula were
prepared by growing with shaking in tryptic soy broth for 24 h and then subse-
quent dilution in RPMIsup to a concentration of 4  107 CFU/ml. Approxi-
mately 2  107 bacteria in 0.5 ml of RPMIsup, containing B. abortus 2308 (wild
type) or its isogenic virB mutant, were added to each well of macrophages. Three
independent assays were performed with triplicate samples, and each experiment
included control (C57BL/6) macrophages together with either Igh6/ or
Cd4/ macrophages. Microtiter plates were centrifuged at 250  g for 5 min at
room temperature in order to synchronize infection. Cells were incubated for 20
min at 37°C in 5% CO2, and free bacteria were removed by three washes with
PBS. RPMIsup plus 50 mg gentamicin per ml was added to the wells, and the
cells were incubated at 37°C in 5% CO2. After 1 h, the RPMIsup plus 50 g/ml
gentamicin was replaced with medium containing 25 g/ml gentamicin. Wells
were sampled at time points between 1 and 48 h after infection by aspirating the
medium, lysing the macrophages with 0.5 ml of 0.5% Tween 20, and rinsing each
well with 0.5 ml of PBS. Viable bacteria were quantified by dilution in sterile PBS
and plating on TSA and TSA plus Km. For macrophage infection with opsonized
bacteria, Brucella abortus 2308 or the virB mutant was treated with a 1:4,000
dilution of naı¨ve rabbit serum, anti-Brucella rabbit serum (Difco), or PBS (non-
opsonized) for 1 h at 37°C, as described by Bellaire et al. (2). This dilution of
both naı¨ve and immune sera was confirmed by microscopy to be nonagglutinating
for Brucella abortus. After opsonization, inocula were prepared and bone mar-
row-derived macrophages infected as described above.
Statistical analysis. For determination of statistical significance between ex-
perimental groups at an individual time point, either a Student’s t test or analysis
of variance (ANOVA) was performed on the data after logarithmic conversion.
A P value of 0.05 was considered significant.
RESULTS
Infection kinetics of the B. abortus wild type and virBmutant
in mice. Determining the time point at which the virB mutant
first begins to be eliminated from the spleen would give some
insight into how the T4SS contributes to persistent infection by
B. abortus. To this end, a mixed infection experiment was used
to assess the level of colonization of both the wild type and the
virB mutant in the same animals. In a previous study, the rate
of clearance of BA41 (virB) from mouse spleens during mixed
infection was found to be comparable to that observed when
mice were inoculated individually with B. abortus BA41 (11).
The results of this study showed that by 14 days postinocula-
tion, approximately 10-fold more wild-type than mutant bac-
teria were recovered from splenic tissue in either mixed or
individual infections, thereby validating the use of mixed in-
fection for our current study.
To determine when the virB mutant begins to be cleared
from splenic tissue, we performed a kinetic study of infection
of BA41 compared to its isogenic wild-type strain 2308 (Fig. 1).
To reproduce the experimental design of the original STM
screens (11, 18), BALB/c mice were used. An inoculum con-
sisting of 5  105 CFU containing a 1:1 mixture of B. abortus
2308, and BA41 (virB) was administered i.p. to the mice.
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Groups of five mice were sacrificed at the time points indicated
for determination of splenic CFU. The results of this experi-
ment showed that the CFU of the virB mutant recovered from
the spleens was nearly identical to that of the wild type at 3
days postinfection (Fig. 1A). The mean log ratio of wild type to
virB mutant in each mouse was also not significantly different
from 1.0 until day 7 postinfection (Fig. 1B), suggesting that the
virB mutant is initially able to colonize the spleen at levels
similar to the wild type.
Based on these results, we hypothesized that one possible
explanation for the different observations obtained using in
vivo and in vitro models could be that, in addition to its de-
scribed effect on intracellular trafficking in macrophages, the
T4SS may allow B. abortus to evade other components of
immunity in vivo. To test this hypothesis, we screened a group
of mutant mice to identify strains that allowed prolonged per-
sistence of the virB mutant.
Since the clearance of the virB mutant from the spleens of
the mice correlated with the development of adaptive immu-
nity, we examined the ability of mice defective in components
of adaptive immunity to eliminate the virB mutant. Many of
these mutant mice are available on a C57BL/6 strain back-
ground but not on a BALB/c background. C57BL/6 mice have
been described as more resistant to B. abortus infection than
BALB/c mice (22); therefore, we repeated the initial experi-
ment using C57BL/6 mice to determine whether the clearance
of the virB mutant proceeded with similar kinetics in this
mouse strain. In this experiment, we included additional time
points to determine more precisely when mice start to clear the
virB mutant. The results (Fig. 2A and B) showed that both the
wild type and the virB mutant colonized C57BL/6 mice at
similar levels during the first 24 h and that a significant differ-
ence (P  0.05) between numbers of B. abortus 2308 and the
virB mutant was first observed at 5 days postinfection. At days
14 and 21 postinfection, the recovery of the virB mutant was
reduced by 2 (day 14) and 3 (day 21) orders of magnitude
compared to the wild type. Thus, although the C57BL/6 mice
cleared the virB mutant more rapidly between 7 and 21 days,
the capacity of the virB mutant to colonize the spleen during
the first few days of infection was similar in both mouse strains.
An IFN- defect does not rescue the virB mutant. To learn
how the T4SS mediates evasion of host immune mechanisms to
initiate persistent infection, we first identified immune mech-
anisms required for clearance of the virB mutant from murine
spleens. Toward this goal, knockout mice with specific defects
in components of the immune response were used to identify
mouse strains with a reduced ability to eliminate the virB
mutant from the spleen. We hypothesized that identification of
mouse mutations that can rescue the virB mutant, but do not
permit increased replication of wild-type B. abortus, may pin-
point immune mechanisms that are circumvented by B. abortus
using its T4SS.
One host response mechanism that has been shown to be
elicited in mice by B. abortus infection during the time when
numbers of the virB mutant start to decline is the production of
IFN- (9, 12). Since IFN- production has been shown to be
crucial for controlling B. abortus infection in mice (22, 32), we
postulated that the Ifng/ mice, which are unable to produce
IFN- (6), might be deficient in controlling replication of the
virB mutant. To test this idea, we performed a mixed infection
study in Ifng/ mice (Fig. 3C) in parallel with C57BL/6 mice
FIG. 1. Kinetics of bacterial load in the spleens of BALB/c ByJ
mice following mixed infection with B. abortus 2308 (wt) and the virB
mutant. Mice were inoculated i.p. with 5  105 CFU of a 1:1 mixture
of wt and the virB mutant. Data points represent the geometric means
of CFU recovered from groups of five mice per time point 	 the
standard error. (A) Log CFU of wt and virB mutant. Asterisks denote
significant differences (P  0.05) between geometric means of virB
mutant and wt CFU as determined with Student’s t test. (B) Compet-
itive index, calculated as the ratio of log CFU virB mutant/log CFU
wild type.
FIG. 2. Kinetics of bacterial load in the spleen following mixed
infection of C57BL/6 mice with B. abortus 2308 (wt) and the virB
mutant. Mice were inoculated i.p. with 5  105 CFU of a 1:1 mixture
of wt and virB mutant. Each data point represents the geometric mean
of CFU recovered from groups of 10 mice per time point 	 the
standard error. For each time point, data are combined from two
independent experiments, each containing five mice per time point.
(A) Log CFU of wt and the virB mutant. Asterisks denote significant
differences (P 0.05) between geometric means of virB mutant and wt
CFU as determined with Student’s t test. (B) Competitive index, cal-
culated as the ratio of log CFU virB mutant/log CFU wild type.
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(Fig. 3A). Based on the infection kinetics determined in
C57BL/6 mice, we chose 14- and 21-day time points for com-
parison of C57BL/6 and knockout mice, as the 2- and 3-log
difference between CFU of the virB mutant and of the wild
type recovered at these time points (Fig. 2A and B) would
enable us to detect significant differences between control and
knockout mice without the use of large groups of experimental
animals.
If IFN--activated macrophages controlled replication of
the virB mutant in vivo, then we expected that the virB mutant
would exhibit increased survival in the Ifng/ mice. However,
the virB mutant was recovered in lower numbers from the
Ifng/ mice than from C57BL/6 controls (Fig. 3A and C),
suggesting that this is not the case. As has been observed
previously (22), wild-type B. abortus was recovered in signifi-
cantly higher numbers from the spleens of Ifng/ mice than
C57BL/6 mice at both 14 (P 
 0.03) and 21 (P 
 0.01) days
postinfection. At days 1 and 21 postinfection, we observed no
significant difference between the ratios of wild-type B. abortus
to virB mutant in Ifng/ mice and the C57BL/6 controls (Fig.
3B and D). On day 14, the Ifng/ mice actually showed in-
creased clearance of the virB mutant compared to the C57BL/6
mice (P  0.05). Based on these results, we concluded that the
Ifng/ mice do not have a specific defect in elimination of the
virB mutant.
Rag1/ mice permit increased splenic persistence of a B.
abortus virB mutant. To determine whether complete inactiva-
tion of adaptive immunity rescues the virB mutant, we com-
pared the ability of Rag1/ mice and the congenic C57BL/6
controls to clear the virB mutant after mixed infection.
Rag1/ mice are unable to generate functional B or T cells
because of a defect in the recombinase-activating gene re-
quired for generating immunoglobulin and T-cell receptor
molecules (21). The results (Fig. 4A and C) of this experiment
showed that both C57BL/6 mice and Rag1/ mice had lower
bacterial loads of the virB mutant than wild-type B. abortus in
the spleen at days 14 and 21. However, the ratio of BA41 (virB)
to B. abortus 2308 (wild type) was higher in the Rag1/ mice
than in the C57BL/6 controls (Fig. 4B and D). The spleens of
Rag1/ mice contained a virB mutant/wt ratio of 1:22 in their
spleens at day 21, whereas the C57BL/6 mice had a splenic virB
mutant/wt ratio of 1:1,200, showing that Rag1/ mice were
deficient at clearing the virB mutant (Fig. 4B and D). Thus, the
Rag1/ mutation caused a partial rescue of the virB mutant in
the mouse spleen without affecting recovery of wt B. abortus.
CD4 T cells and B cells, but not CD8 T cells, contribute
to controlling persistence of the virB mutant. Since Rag1/
mice lack functional CD4 T cells as well as CD8 T cells and
mature B cells, we tested whether mutant mice, in which indi-
vidual genes required for CD4 T-cell, CD8 T-cell, or B-cell
function are knocked out, are also more permissive for persis-
FIG. 3. Recovery of the virB mutant and wild type from spleens of
C57BL/6 mice (A and B) and Ifng/ mice (C and D) after mixed
infection. (A and C) Mean CFU of wild-type and virB mutant B.
abortus recovered from mice (n 
 5). (B and D) Data points are
expressed as competitive index (ratio log CFU mutant/log CFU wt)
and represent the geometric mean of data from five mice 	 the
standard error. Each mouse was infected i.p. with 5 105 CFU of a 1:1
mixture of B. abortus wild type and virB mutant. Graphs are represen-
tative of two independent experiments. Asterisks denote a significant
difference (P  0.05) between geometric means of virB mutant and wt
CFU as determined with Student’s t test. Asterisks in the lower panels
(B and D) indicate a significant difference between geometric means of
CFU recovered from congenic control mice and mutant mice at each
time point. (See text for details.)
FIG. 4. Recovery of virB mutant and wild type from spleens of
C57BL/6 mice (A and B) and Rag1/ mice (C and D) after mixed
infection. (A and C) Mean CFU of wild-type and virB mutant B.
abortus recovered from mice (n 
 15). (B and D) Data points are
expressed as competitive index (ratio log CFU mutant/log CFU wt)
and represent the geometric mean of data from 15 mice 	 the stan-
dard error. Each mouse was infected i.p. with 5 105 CFU of a 1:1
mixture of B. abortus wild type and virB mutant. Data are combined
from three independent experiments, and each group contained five
mice per time point. Asterisks in the upper panels (A and C) denote a
significant difference (P  0.05) between geometric means of virB
mutant and wt CFU, as determined with Student’s t test. Asterisks in
the lower panels (B and D) indicate significant differences between
geometric means of CFU recovered from congenic control mice and
mutant mice at each time point. (See text for details.)
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tence of the B. abortus virB mutant. As with IFN-, CD8 T
cells have been shown to be important for controlling B. abor-
tus infection. Oliveira and Splitter reported that CD8 T cells
isolated from B. abortus-infected mice are able to kill macro-
phages infected in vitro with B. abortus vaccine strain 19 (26).
We reasoned that in vivo, a defect in CD8 T-cell function
might rescue the virB mutant. To test this idea, we performed
mixed infections of C57BL/6 mice and mice deficient in 2-
microglobulin (2m; a subunit of major histocompatibility
complex [MHC] class I), which are unable to generate CD8
cytotoxic T cells due to an inability to synthesize functional
MHC class I protein (33). Figure 5A to D show that both the
absolute numbers of the wild type and virB mutant and the
ratio of virB mutant to wild-type B. abortus recovered from
2m
/ mice were similar at days 1, 14, and 21 postinfection.
These results show that abrogation of CD8 T-cell function in
the 2m
/ mice does not increase the persistence in the
spleen of the virB mutant. These results suggested that the
T4SS does not mediate evasion of CD8 T-cell-dependent
immune functions.
To determine whether mice lacking CD4 T cells can rescue
the B. abortus virB mutant, we performed a mixed infection
study using Cd4/ mice (Fig. 6A to D). At day 1 postinfection,
B. abortus 2308 and the virB mutant were recovered in equiv-
alent numbers from both C57BL/6 mice and the Cd4/ mice,
showing that the T4SS defect in the virB mutant does not affect
initial colonization of either mouse strain. At day 14 postin-
fection, the Cd4/ mice had a higher ratio of virB mutant to
wild type (1:5.7) in the spleens than did C57BL/6 mice (1:300).
Further, at day 14 postinoculation, there were significantly
more CFU of the virB mutant in the spleens of Cd4/ mice
than in the spleens of C57BL/6 mice (P  0.001). Remarkably,
at day 21, the CFU of the virB mutant in spleens of Cd4/
mice were not significantly different from control mice, but
CFU of the wild type were significantly lower (P 
 0.01) in
spleens of the Cd4/ mice than in the spleens of C57BL/6
mice. Thus, the Cd4/ mice reduced CFU of the virB mutant
by 1.5 orders of magnitude during the first 21 days postinfec-
tion, while control mice reduced CFU of the mutant by 3.5
orders of magnitude (Fig. 6A to D).
The finding that the virB mutant was eliminated more slowly
by the Cd4/ mice than by C57BL/6 mice during competitive
infection prompted us to determine whether this was also the
case if mice were inoculated individually with the wild type or
virB mutant (Fig. 7). As observed during mixed infections, the
Cd4/ mice harbored fewer CFU of B. abortus 2308 in the
spleen than C57BL/6 mice at 14 and 21 days after infection
(Fig. 7A). The virB mutant was recovered in similar numbers
from C57BL/6 and Cd4/ mice at day 14, and at day 21
recovery of the mutant from Cd4/ mice was slightly higher
than C57BL/6 mice; however, this difference was not signifi-
cant (Fig. 7B).
Both Rag1/ mice and Cd4/ mice are defective in B-cell
function (21, 27). The lack of functional B cells in these mice
may therefore contribute to the reduced ability of these mice
to clear the virB mutant. To determine whether mice lacking B
cells can clear the B. abortus virB mutant from mice, we per-
formed a mixed infection study using Igh6/ mice and control
mice (Fig. 8A to D). Igh6 / mice are deficient in immuno-
FIG. 5. Recovery of virB mutant and wild type from spleens of
C57BL/6 mice (A and B) and 2m
/ mice (C and D) after mixed
infection. (A and C) Mean CFU of wild-type and virB mutant B.
abortus recovered from mice (n 
 5). (B and D) Data points are
expressed as competitive index (ratio log CFU mutant/log CFU wt)
and represent the geometric means of data from five mice 	 the
standard error. Each mouse was infected i.p. with 5 105 CFU of a 1:1
mixture of B. abortus wild type and virB mutant. Asterisks in the upper
panels denote a significant difference (P  0.05) between geometric
means of virB mutant and wt CFU, as determined with Student’s t test.
Geometric means of CFU recovered from congenic control mice and
mutant mice did not differ significantly (P  0.05).
FIG. 6. Recovery of virB mutant and wild type from spleens of
C57BL/6 mice (A and B) and Cd4/ mice (C and D) after mixed
infection. (A and C) Mean CFU of wild-type and virB mutant B.
abortus recovered from mice (n 
 5). (B and D) Data points are
expressed as competitive index (ratio log CFU mutant/log CFU wt)
and represent the geometric means of data from five mice 	 the
standard error. Each mouse was infected i.p. with 5 105 CFU of a 1:1
mixture of B. abortus wild type and virB mutant. Asterisks in the upper
panels (A and C) indicate a significant difference (P  0.05) between
geometric means of virB mutant and wt CFU as determined with
Student’s t test. Asterisks in the lower panels (B and D) denote sig-
nificant differences between geometric means of CFU recovered from
congenic control mice and mutant mice at each time point. (See text
for details.)
VOL. 75, 2007 B. ABORTUS T4SS AND ADAPTIVE IMMUNITY 2969
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
globulin M heavy chain, which is required for normal B-cell
development (15). At days 14 and 21 postinfection, the Igh6/
mice had a virB mutant to wild type ratio of 1:1.3 in the spleen,
while the ratio in C57BL/6 mice was 1:213. Further, the recov-
ery of the virB mutant from spleens of Igh6/ mice at day 21
was significantly higher than the recovery from C57BL/6 mice
(P  0.01). A second experiment was performed, in which the
wild type and virB mutant were administered individually to
Igh6/ mice (Fig. 7). The results of this experiment showed
that the wild type was recovered from both Igh6/ and control
mice in similar numbers at 14 days postinoculation; however, at
day 21, the Igh6/ mice harbored lower levels of wild-type B.
abortus in the spleen. The virB mutant was recovered in higher
numbers than wild type at day 14 and day 21, but these differ-
ences were not significant. Taken together, the mixed and
individual infection experiments revealed that the Igh6/
mice were slightly better at controlling replication of wild-type
B. abortus but were more permissive for persistence of the virB
mutant. Since the Igh6/ mice exhibited the most marked
defect in clearing the virB mutant and no defect in clearing wt
B. abortus, we chose this mouse strain for further character-
ization.
Macrophages isolated from Igh6/ mice do not differ from
control macrophages in their ability to control replication of
wild-type and virB mutant B. abortus. Since Igh6/ mice per-
mitted persistence of the virB mutant for a longer duration
than control mice, we next asked the question whether the Igh6
mutation could have pleiotropic effects that reduce the ability
of macrophages from these mice to control intracellular rep-
lication. Although Igh6/ mice have been widely used to study
B-cell-dependent responses to infection, no information is
available on whether the Igh6/ mutation affects macrophage
function. However, given the central role of the macrophage as
a site for replication and as an effector cell controlling Brucella
replication, we considered this possibility. To this end, we
compared the ability of macrophages derived from Igh6/
knockout mice to limit intracellular replication of B. abortus
2308 or the virB mutant. For these experiments, a gentamicin
protection assay was used to quantify replication of B. abortus
in bone marrow-derived macrophages isolated from C57BL/6
mice and Igh6/ mice (Fig. 9A and B). Each experiment was
performed in parallel with macrophages from control and
knockout mice. These results showed that wild-type B. abortus
decreased in numbers until 24 h after inoculation and then
exhibited a net increase in CFU between 24 and 48 h. In
contrast, the virB mutant declined below the limit of detection
by 24 h and remained undetectable thereafter. Bone marrow-
derived macrophages isolated from C57BL/6 or Igh6/ mice
did not differ in their ability to control replication of either
wild-type B. abortus or the virB mutant.
Based on these results, we examined whether other macro-
phage populations, namely, adherent splenocytes and resident
peritoneal macrophages isolated from C57BL/6 mice and
Igh6/ mice, differed in their ability to limit replication of the
virB mutant during the first 24 h after inoculation (Fig. 9C to
F). In resident peritoneal macrophages from Igh6/ or con-
trol mice, wild-type B. abortus was present in similar numbers
at 1 h and 24 h postinoculation (Fig. 9C). In contrast, the virB
mutant declined in numbers by 1 order of magnitude between
1 h and 24 h (Fig. 9D). In adherent splenocytes, wild-type B.
abortus exhibited a net increase in numbers between 1 and 24 h
(Fig. 9E), while CFU of the virB mutant decreased by approx-
imately 1 order of magnitude (Fig. 9F). No differences were
observed between cells isolated from C57BL/6 or Igh6/
mice. Taken together, the results of these experiments showed
FIG. 8. Recovery of virB mutant and wild type from spleens of
C57BL/6 mice (A and B) and Igh6/ mice (C and D) after mixed
infection. (A and C) Mean CFU of wild-type and virB mutant B.
abortus recovered from mice (n 
 5). (B and D) Data points are
expressed as competitive index (ratio log CFU mutant/log CFU wt)
and represent the geometric mean of data from five mice 	 the
standard error. Each mouse was infected i.p. with 5 105 CFU of a 1:1
mixture of B. abortus wild type and virB mutant. Asterisks in the upper
panels (A and C) denote a significant difference (P  0.05) between
geometric means of virB mutant and wt CFU as determined with
Student’s t test. Asterisks in the lower panels (B and D) indicate a
significant difference between geometric means of CFU recovered
from congenic control mice and mutant mice at each time point. (See
text for details.)
FIG. 7. Recovery of B. abortus 2308 (A) and the virB mutant
(B) from spleens of control, Igh6 /, and Cd4 / mice following
inoculation with individual strains. Bars represent the geometric
means 	 standard errors of data from groups of five mice, except
where indicated by §, for which n 
 3. Statistical analysis between
geometric means of the CFU of mutant and wild type recovered was
performed using ANOVA. Asterisks denote significant differences
( 
 0.05) between CFU recovered from mutant mice compared to
C57BL/6 mice.
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that the Igh6/ mutation did not affect the ability of macro-
phages to take up or kill either wild-type B. abortus or the virB
mutant after in vitro infection (Fig. 9A to D). Similar results
were obtained using bone marrow-derived or resident perito-
neal macrophages isolated from Cd4/ mice (data not
shown). These results show that the increased in vivo persis-
tence of the virB mutant in Igh6/ mice does not correlate
with an inherent defect in the ability of their macrophages to
control intracellular replication of the virB mutant in vitro.
Killing of the B. abortus virB mutant by macrophages is not
affected by the presence of Brucella-specific antibodies. One
possible explanation for the increased persistence of the virB
mutant in B-cell-deficient Igh6/ mice could be that uptake of
opsonized B. abortus via Fc receptors may lead to increased
killing of the virB mutant by macrophages, compared to wild-
type B. abortus, which has been shown to survive within mac-
rophages after opsonophagocytosis (2). To test this possibility,
we quantified the ability of bone marrow-derived macrophages
to kill B. abortus 2308 or the virB mutant after opsonization
with naı¨ve or B. abortus-immune rabbit serum (Fig. 10). While
opsonization with B. abortus-specific serum increased uptake
of both wild-type and virB mutant B. abortus, resulting in 10-
fold-greater bacterial numbers at 1 h postinfection, this differ-
ence was no longer evident at later time points: at 4, 8, 24, and
48 h, there was no significant difference between intracellular
numbers of opsonized and nonopsonized bacteria.
DISCUSSION
The results of this study demonstrate that the B. abortus
T4SS is not required for initial colonization of mice after i.p.
inoculation but is required for persistence beyond 3 days
postinfection. In light of results from previous studies, in which
Brucella localized to phagocytic cells in the spleens of mice (13,
20, 23), this result was surprising, because data obtained using
infection of macrophages or macrophage cell lines cultivated in
vitro showed a role for the T4SS in intracellular survival that
was manifested as early as 4 to 8 h postinfection (Fig. 9). Our
findings are in accordance with those from Lestrate et al., who
did not identify any virB mutants in two different screens for B.
melitensis signature-tagged mutants attenuated at 5 days
postinfection (18, 19), as well as those of Rajashekara et al.
(28), who showed that a B. melitensis virB mutant was able to
disseminate from the site of injection, suggesting that in B.
melitensis the T4SS is also not essential for initial colonization
of mice. The infection kinetics of the virB mutant in C57BL/6
mice (a decrease in numbers 3 to 5 days after mixed infection
[Fig. 2]) correlate with the timing of adaptive immune re-
sponses, as Brucella-specific IgM antibodies first appear at 3 to
5 days after infection (data not shown). We therefore hypoth-
esized that the T4SS allows B. abortus to evade an immune
mechanism that is activated in the mouse after the first 3 days
of infection.
To test this hypothesis, we screened a group of mutant
FIG. 9. Recovery of B. abortus 2308 or B. abortus virB mutant after
infection of bone marrow-derived macrophages (M) (A and B),
resident peritoneal M (C and D), and adherent splenocytes (E and
F) isolated from C57BL/6 or Igh6/ mice. Each graph represents the
combined data of two or three independent experiments containing
triplicate samples. Data points represent the means 	 standard errors.
No significant differences were observed in the ability of macrophages
from C57BL/6 or Igh6/ mice to control replication of B. abortus 2308
(A, C, and E) or the virB mutant (B, D, and F).
FIG. 10. Recovery of B. abortus 2308 (A) or the B. abortus virB
mutant (B) after opsonization of bacteria and infection of bone mar-
row-derived macrophages. Bacteria were either nonopsonized, opso-
nized with naı¨ve rabbit serum, or opsonized with Brucella-specific
rabbit serum. Each graph represents the combined data of two inde-
pendent experiments containing triplicate samples. Data points repre-
sent the means 	 standard deviations. Significant differences ( 

0.05) between samples were determined by ANOVA and are indicated
with asterisks.
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mouse strains deficient in different immune components to
identify mutations that rescue the survival defect of the virB
mutant. Since the virB mutant BA41 was originally identified
based on its inability to persist during mixed infection with
wild-type B. abortus, we had evidence that coinfection with
wild-type B. abortus does not rescue the virB mutant, for ex-
ample, by type IV secretion of bacterial proteins that may
globally disarm the immune response. Further, in this study as
in a previous study (11), we recovered 100- to 1,000-fold-fewer
CFU of the virB mutant from mice between 14 and 21 days
compared to wild-type B. abortus, irrespective of whether a
mixed inoculum was administered or whether the virB mutant
and wild type were administered separately to mice. Based on
this phenotype, we reasoned that the immune mechanism that
selectively clears the virB mutant must be able to act on virB
mutant bacteria but not on wild-type bacteria in the same
animal. If mice lacked a component of immunity involved in
clearing the virB mutant, then the virB mutant would be ex-
pected to be recovered in higher numbers than from control
mice after mixed infection. The results of these experiments
showed that inactivation of specific immune mechanisms in
mice led to different effects on the ability of the virB mutant
and wt to persist in the spleen (Table 1), suggesting that dif-
ferent immune mechanisms may contribute to limiting persis-
tence of wild-type B. abortus and strains lacking the T4SS.
IFN- production is elicited in B. abortus-infected mice and
was shown to begin between 3 and 7 days postinfection (9),
suggesting that in vivo, IFN- might activate infected cells to
kill the virB mutant selectively. However, our results (Fig. 3)
show that the Ifng/ mutation does not lead to a selective
rescue of the virB mutant. These data are in agreement with
our previous findings that clearance of virB mutants from mice
is not dependent on inducible nitric oxide synthase or NADPH
oxidase (30), which are elicited by IFN-. Similarly, a 2m
/
mutation affecting CD8 T-cell development also failed to
rescue the virB mutant (Fig. 5).
In contrast, a Rag1/ mutation increased the ability of the
virB mutant to persist in the spleen (Fig. 4). Since Rag1/
mice lack mature B and T cells, this result suggested that the
T4SS may enable B. abortus to evade adaptive immunity me-
diated by these cell types. Rag1/ mice have been reported to
be defective in controlling infection with B. melitensis (13).
However, although the Rag1/ mice did not clear the virB
mutant as well as C57BL/6 mice, at 14 and 21 days postinfec-
tion approximately 10-fold more of wild-type than virB mutant
B. abortus was recovered from the spleens of the Rag1/ mice.
Thus, the Rag1/ mice retained some ability to limit persis-
tence of the virB mutant by mechanisms that do not depend on
B and T cells.
Both Cd4/ and Igh6/ mice were less able to eliminate
the virB mutant from the spleen than control mice after mixed
infection (Fig. 6A to D and 8A to D). These results suggested
that B cells and/or CD4 T cells may be involved in clearance
of the virB mutant. While it is tempting to speculate that the
T4SS may enable B. abortus to evade immunity mediated by
these cell types, an important consideration in the interpreta-
tion of these data is that the knockout mice used in this study
may have additional defects or compensatory developmental
changes in their immune systems that may affect their ability to
clear the virB mutant. For example, CD4 T-cell help is re-
quired for antibody responses, and Cd4/ mice have been
shown to generate an antibody response to a model antigen
that was only 10% of that elicited in control mice (27). Con-
versely, B cells have been shown to play a role in CD4 T
helper cell function during murine malaria infection (17).
Therefore, additional approaches will be required to narrow
down the exact defects in these knockout mice that permit
prolonged colonization with B. abortus strains defective in the
T4SS. It should be noted that Cd4/ mice were better able
than control mice to control replication of wild-type B. abortus,
which may be related to a lack of CD4 CD25 regulatory T
cells in the mutant mice.
An Igh6/ mutation leading to an absence of B cells res-
cued the survival defect of the virB mutant. The decreased
ability of Igh6/ mice to limit persistence of the virB mutant
did not appear to be the result of a reduced capacity of their
macrophages to control intracellular replication of the virB
mutant, as bone marrow-derived, splenic, or resident perito-
neal macrophages isolated from these mice were indistinguish-
able from control mice in their ability to limit intracellular
growth of the virB mutant in vitro (Fig. 9). Therefore, the
inability of these mice to prevent persistence of the virB mutant
appears to involve a defect that can only be modeled in vivo.
The macrophage model has yielded important information on
the function of the T4SS in the cell, namely, the subversion of
intracellular trafficking to create the endoplasmic reticulum-
associated replicative compartment (3, 4, 5). Thus, this func-
tion is also expected to be important for T4SS-mediated sur-
vival of Brucella in vivo.
One possible interpretation of our results was that wild-type
B. abortus and the virB mutant may differ in their ability to
survive in macrophages after Fc receptor-mediated phagocy-
tosis and that the absence of specific antibody in the Igh6/
mice could render them more permissive for growth of the virB
mutant. Since it has been shown that B. abortus 2308 opsonized
with immune serum can survive and replicate in human mono-
cytes (2), we tested this possibility and showed that in vitro,
opsonization with immune serum did not affect intracellular
survival of the virB mutant.
An alternative interpretation of our data is that additional
immune components, such as cytokines or cell populations
other than macrophages, may function during infection to
TABLE 1. Effects of mouse mutations on persistence of wild-type and
virB mutant B. abortus relative to responses in C57BL/6 mice
Mouse strain Principal defect
Effect on persistence ofa:
Wild type virB mutant
Ifng/ IFN-  0
2m
/ MHC class I, CD8 T cells 0 0
Rag-1/ B and T cells 0 
Cd4/ CD4 T cells  /0b
Igh6/ B cells 0/c 
a , the B. abortus strain persists at a higher level in mutant mice than in
C57BL/6 mice; , the B. abortus strain persists at a lower level in the mutant
mouse strain than in C57BL/6; 0, no effect on the level of persistence.
b The virB mutant persisted at a higher level in mutant mice after mixed
infection, but no significant difference was observed after individual infection.
c No effect on persistence of wild-type B. abortus was observed after mixed
infection, but after individual infection of Igh6/mice, spleens were colonized at
a lower level 21 days postinfection.
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modulate the ability of macrophages to clear the virB mutant.
The former idea is supported by the finding that human
V9V2 T cells are able to limit intracellular growth of B. suis
within autologous macrophages (25). Thus, one function of the
T4SS may be to interfere with recognition of infected macro-
phages by other immune cells. A second possibility is that the
virB mutant B. abortus may persist in the spleens of Igh6/
and CD4/ mice within a cell population that has a reduced
ability to kill the virB mutant, or that the virB mutant may be
present extracellularly. Location of bacteria in a different cell
population or in an extracellular location may also explain why
the T4SS is not required for survival in the spleen during the
first 3 days after infection. Additional experiments will be re-
quired to distinguish between these different possibilities and
to define the role of the T4SS in immune evasion in vivo. We
anticipate that the results will give us further insights into how
the T4SS enables B. abortus to cause persistent infection.
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